Cocrystal Pharma to Present at the Noble Capital Markets' 21st Emerging Growth Equity Conference

Company Overview - Cocrystal Pharma, Inc. is a clinical-stage biotechnology company focused on developing innovative antiviral treatments for diseases such as influenza, viral gastroenteritis, COVID, and hepatitis [4] - The company utilizes unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs [4] Upcoming Event - James Martin, CFO and co-CEO of Cocrystal, will present a company overview and clinical progress update at NobleCon 21 on December 3, 2025, at 10:00 am Eastern time [1] - The conference will take place at the Executive Education Complex of Florida Atlantic University in Boca Raton, Florida [1] - Interested investors can attend the conference at a discounted rate using the code COCPNOBLECON [2] - A video webcast of the presentation will be available on December 4, 2025, and archived for 90 days on the company's website [2] About Noble Capital Markets - Noble Capital Markets is a research-driven investment bank that has supported small and microcap companies since 1984 [3] - The firm provides institutional-quality equity research, merchant and investment banking, and order execution services [3] - In 2018, Noble launched Channelchek, an investor community dedicated to public small and micro-cap companies, offering free institutional-quality research without a subscription [3]